You can buy or sell Compugen and other stocks, options, ETFs, and crypto commission-free!
Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. Read More The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel.
Holon, Tel Aviv
52 Week High
52 Week Low
Expected Nov 6, Pre-Market